Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006

NCT05414136 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BAT1006

Sponsor

Bio-Thera Solutions